Oriza Seed Venture Capital Co-leads $150M Series C Round In Biopharmaceutical Firm Ascentage Pharma

Ascentage Pharma, a Chinese clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancer and other diseases, announced that it has raised a US$150 million series C round co-led by YuanMing Prudence Fund and Oriza Seed Venture Capital, as well as new investor Teng Yue Partners.

Malaysia’s Sunway Group Co-launches $50M Fund

Sunway Group one of Malaysia’s largest conglomerates and KK Fund –a Singapore-based VC investing in seed stage startups across SEA, jointly established a new venture fund, Sun SEA Capital, with a planned size of $50 million to invest in Southeast Asian and Hong Kong startups according to their website.